Can clinical innovation improve outcomes for least survivable cancers?
MPs consider the extent to which innovation can improve outcomes for some of the least survivable cancers, including pancreatic cancer, brain cancer, and some respiratory cancers. This fifth session in the future cancer inquiry looks at innovations capable of improving poor rates in early diagnosis and lead to increased life expectancy. Treatment and funding for research into less survivable cancers are expected to be examined, along with the impact of existing health inequalities.
Meeting details
The session also considers what the UK can learn from international cancer strategies in the EU and the USA. Research and opportunities for international collaboration are likely to be raised.
The Committee is examining innovations with the greatest potential to transform cancer diagnosis and treatment for patients in the short, medium and long term, and how they can best be transitioned into frontline clinical settings.